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Streptococcus pyogenes [Group A streptococcus (GAS)], a frequent colonizer of the
respiratory tract mucosal surface, causes a variety of human diseases, ranging from
pharyngitis to the life-threatening streptococcal toxic shock-like syndrome. Lactobacilli
have been demonstrated to colonize the respiratory tract. In this study, we investigated
the interference of lactobacilli with the virulence phenotypes of GAS. The Lactobacillus
strains L. rhamnosus Kx151A1 and L. reuteri PTA-5289, but not L. salivarius LMG9477,
inhibited the hemolytic activity of S. pyogenes S165. The inhibition of hemolytic activity
was attributed to a decrease in the production of streptolysin S (SLS). Conditioned
medium (CM) from the growth of L. rhamnosus Kx151A1 and L. reuteri PTA-5289
was sufficient to down-regulate the expression of the sag operon, encoding SLS. The
Lactobacillus strains L. rhamnosus Kx151A1, L. reuteri PTA-5289, and L. salivarius
LMG9477 inhibited the initial adherence of GAS to host epithelial cells. Intriguingly,
competition with a combination of Lactobacillus species reduced GAS adherence to
host cells most efficiently. The data suggest that an effector molecule released from
certain Lactobacillus strains attenuates the production of SLS at the transcriptional
level and that combinations of Lactobacillus strains may protect the pharyngeal mucosa
more efficiently from the initial colonization of GAS. The effector molecules released from
Lactobacillus strains affecting the virulence phenotypes of pathogens hold potential in
the development of a new generation of therapeutics.
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INTRODUCTION
A range of bacterial communities including commensals and pathogens colonize the nasopharynx.
The pharyngeal inhabitant Streptococcus pyogenes [group A streptococcus (GAS)], an adapted
human pathogen, a common colonizer of the mucosa of the mouth, nose, and pharynx, is among
the many pathogens that most often colonize their host asymptomatically and only occasionally
cause disease. Local pharyngeal infection with GAS manifests as pharyngitis and, if spread from
the local site, can cause the systemic diseases sepsis, streptococcal toxic shock syndrome, and
necrotizing fasciitis (Luca-Harari et al., 2009). S. pyogenes produces a wide array of virulence
factors, enabling it to adhere, invade, and spread within the human host (Cunningham, 2008). One
of the characteristic features of S. pyogenes is the ability to lyse red blood cells (RBC), referred to as
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β-hemolysis. S. pyogenes produces two different hemolysins/
streptolysins, streptolysin S (SLS) and streptolysin O. The
reason why S. pyogenes sometimes causes disease is not
entirely understood, but both bacterial virulence factors and
host factors are thought to contribute (Cole et al., 2011).
The microbiota is one such host factor that needs further
investigation. Attachment to epithelial cells is the crucial initial
step of colonization because non-adherent GAS is removed by
mucus and saliva flow. Additionally, bacterial interaction with
the epithelial cells elicits multiple responses in the host cells,
including cell signaling events, and modification of the host
cell transcriptome (Nakagawa et al., 2004). The host responses
regulate the bacterial colonization and play a significant role
in the pathogenesis of the infection (Ribet and Cossart,
2015).
The microbiota prevents colonization with pathogenic
bacteria and represents an important first line of defense.
Mechanisms describing the probiotic effects of Lactobacillus
strains include upregulation of mucin production in the host
cells, interference with host pattern recognition receptors,
competition for essential metabolites, production of antibacterial
molecules, and co-aggregation between the bacteria of the
microbiota and invading pathogenic bacteria, leading to
interference with pathogen adherence to host cells (Lebeer
et al., 2010; Reid et al., 2011; Lievin-Le Moal and Servin,
2014). Lactobacillus species are known to play a significant
role in protection against many gastrointestinal and urogenital
pathogens (Osset et al., 2001; Ostad et al., 2009). However,
less is known about their antagonistic capacity against oral-
pharyngeal pathogens. Additionally, the detailed mechanisms
behind the anti-adhesive properties of lactobacilli and their effect
on the expression of virulence-associated genes are far from fully
understood.
Different species of Lactobacillus are part of the microbiota
of the mucosal membranes in the pharyngeal tract (Badet
and Thebaud, 2008). The study, therefore, aimed to investigate
whether Lactobacillus strains interfere with the expression of the
virulence-associated factors of S. pyogenes and its ability to adhere
to pharyngeal epithelial cells.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
All Lactobacillus strains were isolated from healthy human
individuals. Lactobacillus rhamnosus Kx151A1, isolated from a
gastric biopsy, has been described previously (Roos et al., 2005).
The Lactobacillus salivarius LMG9477, a type strain from the
Belgian Coordinated Collections of Micro-organisms (BCCM),
and Lactobacillus reuteri ATCC: PTA-5289, a kind gift from
BioGaia AB, Stockholm were isolated from the oral cavity
and have been described previously (de Klerk et al., 2016).
Lactobacilli were grown on Rogosa agar plates and cultured in
MRS broth (Oxoid, Thermo Fisher Scientific, Hampshire, UK).
S. pyogenes S165 (GAS), serogroup emm6, was isolated from a
septic patient (Sjolinder et al., 2008). GAS was grown on GC agar
(Acumedia, Lansing, MI, USA) containing Kellogg’s supplement
(Kellogg et al., 1963). All bacteria were cultured at 37◦C and 5%
CO2.
Cell Lines and Culture Conditions
The pharyngeal epithelial cell lines FaDu (ATCC: HTB-43),
and Detroit 562 (ATCC: CCL-138) were cultured in DMEM
with GlutaMAX and pyruvate (Invitrogen, Carlsbad, CA, USA)
supplemented with 10% heat-inactivated fetal bovine serum
(Sigma–Aldrich, St. Louis, MO, USA). The cells were maintained
at 37◦C and 5% CO2 in a humidified environment. In all
experiments, epithelial cells were seeded into cell culture plates
the day before experiments to reach 90% confluence. The cell
medium was replaced with serum-free DMEM half an hour
before the experiments.
Conditioned Media (CM)
Lactobacilli were grown on Rogosa agar plates. The bacteria
were scraped off, washed twice with Todd–Hewitt broth (THB),
and resuspended in THB. From this suspension, the growth of
lactobacilli was initiated by adjusting to A600 ≈0.1 in THB. The
growth was monitored until the density reached A600 ≈ 1.0.
The lactobacilli were removed by centrifugation. The supernatant
was passed through a 0.2 µm filter, adjusted to pH 7.8 and
supplemented with 2% tryptone to obtain the Conditioned Media
(CM, Saroj and Rather, 2013).
Hemolytic Activity
Group A streptococcus was cultured in THB, co-incubated with
lactobacilli, or in CM. For co-incubation, GAS and lactobacilli
from agar plates were suspended in THB at A600 = 0.1
in the proportion of 1:1. At the desired time point, the
bacteria were harvested by centrifugation; the supernatants were
passed through a 0.2 µm filter and used for the hemolytic
assay. RBCs for hemolytic assays were prepared from horse
blood (Håtunalab AB, defibrinated) by washing three times in
phosphate buffered saline (PBS) and diluting to 2% in PBS.
The supernatants were diluted 1:10, mixed 1:1 with RBCs and
incubated at 37◦C in 5% CO2 for 1 h. The RBCs were removed
by centrifugation at 2000 g for 3 min, and the supernatant
was analyzed at A404 for hemolysis. Hemolytic activity was
reported as the percentage relative to water alone. The SLS-
mediated hemolytic activity was confirmed using trypan blue
and cholesterol binding assays as SLS gets inhibited in the
presence of trypan blue and SLO by cholesterol (Sierig et al.,
2003). For all assays, the hemolytic activity was examined in
the presence of trypan blue and cholesterol. The hemolytic
activity of GAS in lactobacilli supernatants was measured by
harvesting the supernatants at 1 h intervals until the growth
reached the stationary phase. For hemolytic activity of GAS
supernatant in co-incubation with CM, supernatant from the
growth of GAS in THB from A600 ≈ 0.1 to A600 ≈ 1.0
was obtained. The supernatant was mixed with THB, or
with CM from L. salivarius (L.sa), L. rhamnosus (L.rh), or
L. reuteri (L.re) in a proportion of 1:1 and incubated for
30 min at 37◦C with 5% CO2 prior to measuring the hemolytic
activity.
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Viable Count
To asses the viability of GAS, viable count was performed by serial
dilutions and plating on GC agar. In co-incubation experiments,
the bacteria could be distinguished by colony size; GAS formed
colonies larger than lactobacilli.
Quantitative PCR Assays
Group A streptococcus was grown alone or co-incubated with
lactobacilli in THB or in CM to A600 ≈ 1.0. The cells were
harvested by centrifugation and total RNA was isolated using
an RNeasy mini kit (Qiagen) after treatment with mutanolysin
for 1 h. Total RNA 200 ng was reverse transcribed to cDNA using
SuperScript VILOTM master mix (ThermoFisher Scientific). The
primers sagA-RT-(F) 5′GCTACTAGTGTAGCTGAAACAACT
CAA-3′ and sagA-RT-(R) 5′AGCAACAAGTAGTACAGCAGC
AA-3′ were used for the qPCR. The following conditions were
used: an initial denaturation step at 95◦C for 10 min; 45 cycles at
95◦C for 15 s and 60◦C for 1 min. The fold change was measured
in relation to the housekeeping gene gyrA using the primers
gyrA-RT-(F) 5′CGACTT GTCTGAACGCCAAAGT3′ and gyrA-
RT-(R) 5′ATCACGTTCCAAACCAGTCAAAC3′.
Luciferase Assay
The transcriptional fusion for the luciferase assay was
prepared using pKSM720, which encodes a promoterless
firefly luciferase (Almengor et al., 2007). The 400 bp
region upstream of the sag operon was amplified using the
primers sagAPro-F- 5′CCTGAGGATCCGTATTAGCGAGGTA
AAG3′ and sagAPro-R- 5′AGTCACTCGAGAAGGTTTACCTCC
TTATC3′. The fragments were gel purified, digested with
BamHI and XhoI and cloned into the BglII and XhoI site of
pKSM720. The resulting construct, pKSM720-sagApro-luc, was
electroporated into GAS. Spectinomycin at 50 µg/ml was used to
maintain the plasmid. The GAS with the construct was grown in
THB or CM from lactobacilli from A600 ≈ 0.1 to A600 ≈ 1.0, and
the luciferase activity measured according to the manufacturer’s
instructions (Promega). The assay was conducted in the absence
of spectinomycin. The maintenance of the plasmid construct was
confirmed from the viable counts on THY plates with or without
spectinomycin.
Adherence Assays
Adherence assays were performed as previously described
(Maudsdotter et al., 2011). FaDu (ATCC: HTB-43) or Detroit
562 (ATCC: CCL-138) pharyngeal epithelial cells were cultured
in a 48-well plate and were inoculated with GAS at an
MOI of 100 or together with lactobacilli at an MOI of 100
for 2 h. In competition assays, GAS and lactobacilli were
added simultaneously. In exclusion assays, lactobacilli were pre-
incubated with epithelial cells for 2 h followed by washing
to remove unbound bacteria before the addition of GAS. In
displacement assays, GAS was pre-incubated with the epithelial
cells for 2 h followed by washing before addition of lactobacilli.
When mixtures of lactobacilli were used, an MOI of 100 for
each strain was added to the epithelial cells. After incubation,
unbound bacteria were removed by washing in the medium.
Adhered bacteria were quantified from viable counts obtained by
lysing the epithelial cells for 5 min in 1% saponin and plating
on GC plates. The adherence of GAS alone was normalized
to 1.
Statistical Analysis
All the experiments were performed in triplicate and repeated
three times. Analysis of variance (ANOVA) and Tukey’s HSD
(honestly significantly different) test (Statistica) was used to
analyze differences between the groups for statistical significance.
Statistical analysis of ratios or relative values was performed
on log ratios. A p-value below 0.05 was considered statistically
significant. Error bars represent standard deviation.
RESULTS
Certain Lactobacilli Inhibit the Hemolytic
Activity of S. pyogenes
We investigated the influence of lactobacilli on the hemolytic
activity of GAS. GAS was co-incubated with different
Lactobacillus strains in THB and assayed for hemolytic activity.
L. rhamnosus Kx151A1 (L. rh) and L. reuteri PTA-5289 (L. re)
inhibited the hemolytic activity of GAS (Figure 1A). However, L.
salivarius LMG9477 (L. sa) had no effect. The hemolytic activity
was mediated by SLS because the presence of trypan blue, but not
cholesterol, blocked the hemolytic activity (data not shown). To
rule out the possibility that lactobacilli may inhibit the growth of
GAS or affect the pH, we performed viable counts and measured
the pH in the medium. The incubation of GAS with lactobacilli
did not affect the survival of GAS (Figure 1B). Additionally, the
pH of the growth media was not significantly affected during
the co-incubation (Figure 1C). These results show that certain
lactobacilli block the SLS-mediated hemolytic activity of GAS.
Lactobacillus Growth Supernatant
Inhibits the Hemolytic Activity of
S. pyogenes
To examine whether the inhibition of hemolytic activity was due
to molecules released from lactobacilli, a conditioned medium
(CM) was prepared from the growth supernatants of lactobacilli.
The hemolytic activity of GAS in the CM was assessed at regular
intervals. The SLS-mediated hemolytic activity was inhibited in
GAS grown in the CM from L. rhamnosus (L. rh) and L. reuteri
(L. re) throughout the growth period (Figure 2A). As previously
reported, hemolytic activity was detected during the logarithmic
phase and reached a maximum in the stationary phase (Kinkel
and McIver, 2008). The growth of GAS was not affected in the CM
(Figure 2B). These results indicate that the inhibitory molecule is
a component released from lactobacilli.
To examine whether the released effector molecule binds
directly to SLS, supernatants from the growth of GAS in THB
were mixed with the CM of lactobacilli and assayed for hemolytic
activity. There was no observable difference in the hemolytic
activity of the GAS supernatant mixed with fresh THB and the
GAS supernatant mixed with CM from lactobacilli (Figure 2C).
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FIGURE 1 | Lactobacilli inhibit the hemolytic activity of Group A streptococcus (GAS). (A) Hemolytic activity of GAS grown alone or co-incubated with
Lactobacillus rhamnosus (L. rh), L. reuteri (L. re), or L. salivarius (L. sa) in THB. (B) Viable count of GAS (C) pH of the supernatant from the growth of GAS in THB
alone or co-incubated with lactobacilli. Significant differences are marked with asterisks.
FIGURE 2 | Lactobacillus growth supernatant inhibits the hemolytic activity of GAS (A) Hemolytic activity of GAS grown in THB, CM of L. rhamnosus
(L. rh) and L. reuteri (L. re). (B) Growth curve of GAS in THB and CM. (C) Hemolytic activity of GAS supernatant in co-incubation with CM. The supernatant
obtained from the growth of GAS in THB was mixed with CM.
These data suggest that Lactobacillus strains release or secrete a
soluble effector molecule that inhibits the hemolytic activity of
GAS.
Lactobacilli Interfere with the Expression
of the sag Operon
Streptolysin S is chromosomally encoded by a contiguous nine-
gene sag operon (Borgia et al., 1997; Molloy et al., 2011).
The first gene of the operon is sagA, which encodes a 53
amino acid precursor. The expression of sagA during the co-
incubation of GAS with lactobacilli was monitored by qPCR.
There was no significant (P ≥ 0.05) change in the expression
of sagA when GAS was co-incubated with L. salivarius (L.
sa) (Figure 3A). However, when GAS was co-incubated with
cultures of L. rhamnosus (L. rh) and L. reuteri (L. re), a
significant (P < 0.01) decrease in sagA expression was observed.
A similar effect was observed in the expression of sagA with
GAS cultured in the CM of lactobacilli (Figure 3B). CM
from L. rhamnosus (L. rh) and L. reuteri (L. re), but not
L. salivarius (L. sa), inhibited sagA expression. The results
indicate that the decrease in the hemolytic activity of GAS by
lactobacilli is due to a decrease in the expression of the sag
operon.
Lactobacilli Interfere with the Promoter
Activity of the sag Operon
To confirm that the effector molecule released from Lactobacillus
inhibits the SLS at the transcriptional level, we constructed
a transcriptional fusion of the promoter region of the sag
operon to a promoterless luciferase reporter gene, sagApro-luc.
GAS harboring sagApro-luc exhibited the expected luciferase
activity when grown in THB. However, the luciferase activity
was inhibited when the GAS with sagApro-luc was cultured
in the CM from L. rhamnosus (L. rh) and L. reuteri (L. re)
(Figure 4), whereas the CM of L. salivarius (L. sa) had no
effect. The data demonstrate that a lactobacilli-released effector
molecule regulates the GAS SLS-mediated hemolytic activity at
the transcriptional level.
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FIGURE 3 | Lactobacilli interfere with the expression of sagA. (A) Expression of sagA during co-incubation of GAS with lactobacilli (B) Influence of the
Lactobacillus effector molecule in CM on the expression of sagA. Significant differences are marked with asterisks.
FIGURE 4 | Lactobacilli released component affects the promoter
activity of sagA. A luciferase assay was performed to determine the effect of
the Lactobacillus-released effector molecule on the promoter activity of sagA.
Significant differences are marked with asterisks.
Lactobacilli Inhibit the Adherence of GAS
to Host Epithelial Cells
In addition to their effect on hemolytic activity, we also
investigated if lactobacilli have an effect on the initial adherence
of GAS to pharyngeal epithelial cells. All the Lactobacillus
isolates, i.e., L. rhamnosus (L. rh), L. reuteri (L. re), and
L. salivarius (L. sa), significantly (P ≤ 0.01) reduced the
adherence of GAS by approximately 35% in a competition
assay (Figure 5A). Additionally, all three Lactobacillus isolates
significantly (P ≤ 0.01) inhibited streptococcal adherence when
pre-incubated with the host cells for 2 h before the addition
of GAS in exclusion assays. However, in the exclusion assays,
a difference between the Lactobacillus isolates was observed:
L. rhamnosus and L. reuteri inhibited streptococcal adherence by
approximately 35%, whereas approximately 20% inhibition was
observed with L. salivarius. Additionally, the ability of lactobacilli
to displace already-adhered GAS was tested. L. salivarius
significantly (P≤ 0.01) inhibited streptococcal adherence by 35%
in displacement assays. In contrast, neither L. rhamnosus nor
L. reuteri displaced adhered GAS. In a previous study, we showed
that co-incubating GAS with lactobacilli for longer time points
(4–16 h) reduced GAS viability and thereby reduced the number
of viable GAS adhered to host cells (Maudsdotter et al., 2011).
However, co-incubating host cells with GAS and lactobacilli for
2 h did not affect streptococcal viability (Figure 5B). These
data show that lactobacilli significantly reduce GAS adherence to
epithelial cells.
Effect of Different Combinations of
Lactobacillus Strains on the Adherence
of GAS
Different combinations of Lactobacillus isolates were co-
incubated with GAS to evaluate whether a combination of
lactobacilli enhanced the anti-adhesive effect. A combination of
L. rhamnosus (L. rh) or L. reuteri (L. re) with L. salivarius (L.
sa) conferred a significantly (P ≤ 0.01) higher level of inhibition
compared to co-incubation with any of the Lactobacillus isolates
alone (Figure 6A). However, a combination of L. rhamnosus
(L. rh) and L. reuteri (L. re) did not enhance the anti-adhesive
effect compared to each species alone (Figure 6A). The effect
of different combinations of lactobacilli on GAS adherence was
tested in an additional cell line, pharyngeal epithelial Detroit
562 cells, and the same effects were observed (Figure 6B). Thus,
a combination of Lactobacillus strains can increase the anti-
adhesive effect.
DISCUSSION
Group A streptococcus and lactobacilli are both part of
the pharyngeal microbiota. This study aimed to investigate
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FIGURE 5 | Lactobacilli inhibit GAS adherence to pharyngeal epithelial host cells. (A) Adherence of GAS to FaDu epithelial cells in a competition, exclusion
and displacement assay (B) Recovery of GAS after co-infection with lactobacilli for 2 h. Significant differences are marked with an asterisk.
FIGURE 6 | Group A streptococcus adherence to epithelial cells in competition with different combinations of lactobacilli. GAS adherence to (A) FaDu
cells and (B) Detroit 562 cells after infection alone or together with L. salivarius (L.sa), L. rhamnosus (L.rh), and L. reuteri (L.re) for 2 h. Significant differences are
marked with an asterisk.
how lactobacilli affect the virulence phenotypes of GAS in
terms of hemolytic activity and adherence to host epithelial
cells.
Lactobacilli are a heterogeneous group of bacteria.
Additionally, it has been previously reported that different
lactobacillus isolates vary widely in their ability to interfere
with the virulence mechanisms of pathogens (Osset et al., 2001;
Ekmekci et al., 2009; Ostad et al., 2009). GAS infections have
been attributed to the variety of secreted and surface-bound
virulence factors. One of the most important virulence factors
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encoded by GAS is SLS (Ginsburg, 1999). In addition to
the ability to lyse RBCs, SLS has been shown to damage
the cell membranes of lymphocytes, neutrophils, platelets,
lysosomes, and mitochondria, indicating an important role
for SLS in S. pyogenes pathogenesis (Ginsburg, 1999; Molloy
et al., 2011). In this study, we found that lactobacilli were
able to inhibit the hemolytic activity of GAS. Moreover,
CM from the growth of lactobacilli was sufficient to inhibit
SLS production. The transcriptional fusion and qPCR data
revealed that this effect takes place at the transcriptional
level. The secreted components from lactobacilli negatively
regulate the promoter activity and down-regulate the sag
operon.
Incoming pathogens must compete with the resident
microbiota for nutrients and space to colonize the mucosal
membranes in the body. Additionally, the microbiota modulate
immune responses, produce inhibitory substances and prevent
the attachment of pathogens and in this way protect the
host from infections (Lebeer et al., 2010). Lactobacilli of
different species belong to the microbiota of the pharynx,
the gastric tract, and the urogenital tract and inhibit the
adherence of many pathogens (Alexandre et al., 2014; Ribet and
Cossart, 2015). In a few studies, the Lactobacillus components
mediating adherence inhibition have been identified; lactobacilli
produce biosurfactants (Servin, 2004; Rizzo et al., 2013),
S-layer proteins (Velraeds et al., 1996, 1998; Spurbeck and
Arvidson, 2010), and surface-located enolase (Ren et al.,
2012), which have been reported to inhibit the adherence
of different pathogens. However, the mechanisms by which
Lactobacillus species inhibit the adherence of pathogens are
still largely unknown. Some studies have reported a similar
level of adherence inhibition when lactobacilli are added
to host cells together with the pathogen as that observed
when lactobacilli pre-colonize the host cells (Lee et al.,
2003; Zhang et al., 2010). Other studies have reported a
stronger inhibition of lactobacilli pre-colonizing the host
cells when compared to lactobacilli added simultaneously
with the pathogen (Vielfort et al., 2008). In this study, we
demonstrate that L. rhamnosus Kx151A1, L. reuteri PTA-
5289, and L. salivarius LMG9477 reduced the adherence of
GAS to the host epithelial cells. In addition, we observed
that L. salivarius conferred stronger protection when added
in competition with GAS compared to when it pre-
colonized the host cells. Further, L. salivarius was the only
Lactobacillus species with the ability to displace already-
adhered GAS. Our results highlight the differences between
Lactobacillus species in the mechanism by which they confer
colonization resistance as well as the effects they exert on host
cells.
Various Lactobacillus species have previously been found
to exhibit bactericidal activities against GAS in co-infection
studies. In a previous study, we showed that co-incubation
with lactobacilli for longer time points caused elevated lactic
acid concentrations that are bactericidal against GAS and
thereby reduce the number of viable GAS adhered to host
cells (Almengor et al., 2007). In this study, we investigated the
influence of lactobacilli on GAS adherence at a shorter time
point at which GAS was not killed and observed inhibition
of the initial adherence that was independent of compromised
viability.
Thus, colonization with Lactobacillus species impairs GAS
pathogenicity at different stages of infection, both by reducing
the adherence at earlier stages and by affecting the viability after
prolonged incubation and attenuating the hemolytic activity.
Probiotics are live microorganisms that confer health benefits
on the host. Lactobacillus is a well-studied genus for probiotic
use. Many criteria have been suggested for the selection of
probiotics, including their ability to prevent the adherence
of pathogens to target cells (Lee et al., 2003; Lebeer et al.,
2010). The effects of probiotics are strain-specific, and the
mechanisms of protection are largely unknown. The current
study reveals that lactobacilli interfere with the virulence
phenotypes of GAS in terms of SLS production and adherence
to the host epithelial cells. Furthermore, a combination of
lactobacilli has a greater effect in reducing the adherence of
GAS to host epithelial cells and thus has an enhanced protective
effect.
The findings may have a potential application in the use
of lactobacilli strains as a probiotic for oral health purposes
to combat GAS infections. Also, the secreted component
from the lactobacilli holds a therapeutic value to fight GAS
infections.
The identification of the Lactobacillus-secreted product
interfering with the transcription of the sag operon is under
study. Greater understanding of the molecular mechanisms by
which probiotics function will help in developing enhanced
future therapeutics.
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